(compared with the corresponding period a year ago)
- Net sales increased 12.1% to
SEK 147,147m (131,320). Sales growth, including organic sales growth and acquisitions, amounted to 6.7%, of which volume accounted for -3.7%, price/mix for 9.5% and acquisitions for 0.9%. -
Operating profit before amortization of acquisition-related intangible assets (EBITA) increased 68% to
SEK 16,607m (9,876) -
Adjusted EBITA increased 57% to
SEK 18,898m (12,047) and the adjusted EBITA margin increased 3.6 percentage points to 12.8% (9.2) -
Profit for the period continuing operations increased 84% to
SEK 9,517m (5,165) -
Earnings per share continuing operations increased to
SEK 13.44 (7.28) and adjusted earnings per share continuing operations increased 51% toSEK 17.56 (11.60) -
Operating cash flow increased 130% to
SEK 17,685m (7,680) - Return on capital employed increased to 14.4% (8.9) and the adjusted return on capital employed increased 5.5 percentage points to 16.4% (10.9)
Isola Castle Ltd , a company indirectly wholly owned byAsia Pacific Resources International Limited (APRIL), has announced that it will make a pre-conditional public offer to the shareholders ofVinda International Holdings Limited (Vinda) to acquire 100% of the shares in Vinda for a price per share ofHKD 23.50 .Essity supports the offer and has signed an irrevocable undertaking to accept the offer in respect of all of its 51.59% shareholding in Vinda.-
The Board of Directors proposes an increase in the dividend of 7% to
SEK 7.75 (7.25) per share
CEO'S COMMENTS
Highest profit ever and strong platform for growth
Structurally improved profitability
We can look back at a year with high sales growth and a significantly higher EBITA margin, where all business areas made positive contributions through profitable growth and margin improvements. Measures aimed at structurally improving profitability have had an effect. In Health & Medical, decisive price increases have led to a sharp increase in the margin. For Professional Hygiene, restructuring measures in
The adjusted return on capital employed improved in 2023 by 5.5 percentage points to 16.4%. Adjusted earnings per share were
Strong fourth quarter
For the fourth quarter, sales growth, including organic sales growth and acquisitions, was -0.7%. Volumes were lower, mainly due to the focus on profitable growth and decisions earlier in the year to carry out restructuring measures and exit contracts with insufficient profitability. These decisions have long-term improved
Portfolio shift
We have continued to grow in the categories and sales channels with the highest market growth and returns. The earlier acquisitions of, for example, Knix, Hydrofera and Legacy, have strengthened our offerings and contributed with high growth.
We have undertaken to accept the offer from
An even more sustainable
By providing hygiene and health solutions to a billion people every day across the globe,
Focus on profitable growth in 2024
Following many measures in 2023 and a structurally improved profitability, we have a strong platform for future growth.
President and CEO
FUTURE REPORTS
ANNUAL GENERAL MEETING
INVITATION TO PRESENTATION OF THE YEAR-END REPORT FOR 2023
In conjunction with publication, a telephone and web presentation will be held at
Presentation
Date:
Time:
Link to web presentation: https://essity.videosync.fi/2024-01-25
Telephone:
The presentation of the Year-end report will also be broadcast live on LinkedIn and X (Twitter).
President and CEO
For further information, please contact:
Sandra Åberg, Vice President Investor Relations, Group Function Finance, +46 (0) 70 564 96 89
Per Lorentz, Vice President Corporate Communications, Group
NB:
This interim report has not been reviewed by the company's auditors.
This information is such that
https://news.cision.com/essity/r/year-end-report-2023,c3915146
https://mb.cision.com/Main/15798/3915146/2561965.pdf
(c) 2024 Cision. All rights reserved., source